These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20701970)

  • 1. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
    Wilkins BS
    Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant proplatelet formation in chronic myeloproliferative neoplasms.
    Muth M; Büsche G; Bock O; Hussein K; Kreipe H
    Leuk Res; 2010 Nov; 34(11):1424-9. PubMed ID: 20430444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal clones of megakaryocytes in myeloproliferative disorders.
    Sato Y; Suda T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1705-18. PubMed ID: 3471029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
    Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
    Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?].
    Wehmeier A; Schneider W
    Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
    Santana-Davila R; Tefferi A; Holtan SG; Ketterling RP; Dewald GW; Knudson RA; Steensma DP; Chen D; Hoyer JD; Hanson CA
    Leuk Res; 2008 Dec; 32(12):1927-30. PubMed ID: 18538839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow in megakaryocytic disorders.
    Burkhardt R
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):695-733. PubMed ID: 3065325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detangling fibrosis assessment in MPNs.
    Mesa RA
    Leuk Res; 2010 Jul; 34(7):854-5. PubMed ID: 20137811
    [No Abstract]   [Full Text] [Related]  

  • 12. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly].
    Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T
    Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of the myeloproliferative syndrome from the pathologist's viewpoint].
    Werner W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):227-34. PubMed ID: 4184585
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myelofibrosis.
    Rupani M
    Am J Clin Pathol; 1982 Apr; 77(4):475-8. PubMed ID: 6951405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
    Nagao T; Yonekura S
    Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioptic medullary findings for the formation of fibres in attended and not yet attended myeloses (author's transl)].
    Hill K; Dennhardt HH
    Verh Dtsch Ges Pathol; 1972; 56():587-92. PubMed ID: 4130904
    [No Abstract]   [Full Text] [Related]  

  • 18. Classification of myeloproliferative disorders by bone marrow histology.
    Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G
    Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary myelofibrosis and its paraneoplastic stromal effects.
    Tefferi A
    Haematologica; 2007 May; 92(5):577-9. PubMed ID: 17488678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary myeloid splenomegalies and accompanying myeloid splenomegalies].
    Gallais H; Casanova P; Muratore R; Olmer J
    Nouv Presse Med; 1972 Apr; 1(16):1063-4. PubMed ID: 5035860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.